Barclays Has Lowered Expectations for Intellia Therapeutics (NASDAQ:NTLA) Stock Price
Intellia Therapeutics (NASDAQ:NTLA – Free Report) had its target price reduced by Barclays from $55.00 to $26.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the stock.
Verisk Analytics (NASDAQ:VRSK) Price Target Raised to $297.00 at BMO Capital Markets
Verisk Analytics (NASDAQ:VRSK – Free Report) had its price target hoisted by BMO Capital Markets from $280.00 to $297.00 in a research report released on Thursday,Benzinga reports. BMO Capital Markets currently has a market perform rating on the business services provider’s stock.
Barclays Keeps Their Buy Rating on Extra Space Storage (EXR)
In a report released today, Brendan Lynch from Barclays maintained a Buy rating on Extra Space Storage (EXR – Research Report), with a price
Cubesmart (CUBE) Receives a Hold from Barclays
In a report released today, Brendan Lynch from Barclays maintained a Hold rating on Cubesmart (CUBE – Research Report), with a price target of
Bloomberg L.P.6d
BMO Beats Estimates as Capital Markets Post Strong Performance
Bank of Montreal beat estimates as it benefited from strong performance in its capital-markets business and set aside less money than expected to cover possible loan losses. The Canadian bank ...
Yahoo Finance6d
BMO, Scotiabank Beat Estimates on Capital-Markets Results
(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.